CAM
BIIB icon

Cidel Asset Management’s Biogen BIIB Stock Holding History

Cidel Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Sell
1,952
-177
-8% -$33.9K 0.02% 298
2026
Q1 		$390K Buy
2,129
+190
+10% +$35K 0.02% 281
2025
Q4 		$341K Sell
1,939
-85
-4% -$13.9K 0.02% 257
2025
Q3 		$284K Buy
2,024
+162
+9% +$21.9K 0.02% 281
2025
Q2 		$234K Buy
1,862
+190
+11% +$23.7K 0.01% 318
2025
Q1 		$229K Buy
1,672
+160
+11% +$22.9K 0.02% 297
2024
Q4 		$231K Buy
1,512
+191
+14% +$32.2K 0.02% 299
2024
Q3 		$256K Buy
1,321
+101
+8% +$21.1K 0.02% 287
2024
Q2 		$283K Buy
1,220
+118
+11% +$25.6K 0.02% 256
2024
Q1 		$238K Buy
1,102
+66
+6% +$15.5K 0.02% 286
2023
Q4 		$268K Buy
+1,036
New +$254K 0.01% 257

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cidel Asset Management's BIIB Position: Q2 2026 in Review

Cidel Asset Management reduced its Biogen (BIIB) stake by 8.3% in Q2 2026, selling an estimated $33.9K and leaving 1,952 shares worth $422K. The position accounts for 0.02% of the portfolio, ranked #298.

Cidel Asset Management first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Cidel Asset Management held 1,952 shares of Biogen worth $422K as of Q2 2026.
  • Cidel Asset Management sold 177 Biogen shares in Q2 2026, an estimated $33.9K.
  • Biogen made up 0.02% of Cidel Asset Management's portfolio in Q2 2026, its #298 holding.
  • Cidel Asset Management first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.